Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramesh Mullangi

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|November 18, 2017
LC-ESI-MS/MS determination of defactinib, a novel FAK inhibitor in mice plasma and its application to a pharmacokinetic study in miceGurulingappa Hallur, Natarajan Tamizharasan, Suresh P Sulochana, et al.
Biomedical Chromatography : BMC|November 19, 2015
LC-MS/MS assay for the determination of lurasidone and its active metabolite, ID-14283 in human plasma and its application to a clinical pharmacokinetic studyMahitej Yadav Katteboina, Nageswara Rao Pilli, Ramesh Mullangi, et al.
Drug Development and Industrial Pharmacy|February 19, 2020
Preparation and optimization of nilotinib self-micro-emulsifying drug delivery systems to enhance oral bioavailabilityAshok Zakkula, Bhavesh Babulal Gabani, Ravi Kumar Jairam, et al.
Biomedical Chromatography : BMC|January 31, 2020
Validated LC-MS/MS method for quantitation of a selective JAK1 inhibitor, filgotinib in rat plasma, and its application to a pharmacokinetic study in ratsAbhishek Dixit, Vinay Kiran, Bhavesh Babulal Gabani, et al.
Biomedical Chromatography : BMC|July 25, 2020
A dried blood spot assay with HPLC-MS/MS for the determination of larotrectinib in mouse blood and its application to a pharmacokinetic studyHarsha K Tripathy, Nair S V Manju, Sreekanth Dittakavi, et al.
Biomedical Chromatography : BMC|January 28, 2015
Development and validation of a RP-HPLC method for the quantitation of tofacitinib in rat plasma and its application to a pharmacokinetic studyVijay Kumar S, Vinay Dhiman, Kalpesh Kumar Giri, et al.
Biomedical Chromatography : BMC|July 25, 2016
Determination of epacadostat, a novel IDO1 inhibitor in mouse plasma by LC-MS/MS and its application to a pharmacokinetic study in miceVinay Dhiman, Kalpesh Kumar Giri, Suresh P S, et al.
Biomedical Chromatography : BMC|February 23, 2012
Development and validation of a highly sensitive LC-MS/MS-ESI method for the determination of nobiletin in rat plasma: application to a pharmacokinetic studyAvinash Kumar, V C Devaraj, Kalpesh C Giri, et al.
Biomedical Chromatography : BMC|May 1, 2012
Simultaneous determination of sitagliptin and simvastatin in human plasma by LC-MS/MS and its application to a human pharmacokinetic studyLaxminarayana Burugula, Ramesh Mullangi, Nageswara Rao Pilli, et al.
Biomedical Chromatography : BMC|September 28, 2010
Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic studySandip Dhondiram Gurav, Ravindranath Reddy Gilibili, Sherine Jeniffer, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Journal of Pharmaceutical and Biomedical Analysis|November 18, 2017
LC-ESI-MS/MS determination of defactinib, a novel FAK inhibitor in mice plasma and its application to a pharmacokinetic study in miceGurulingappa Hallur, Natarajan Tamizharasan, Suresh P Sulochana, et al.
Biomedical Chromatography : BMC|November 19, 2015
LC-MS/MS assay for the determination of lurasidone and its active metabolite, ID-14283 in human plasma and its application to a clinical pharmacokinetic studyMahitej Yadav Katteboina, Nageswara Rao Pilli, Ramesh Mullangi, et al.
Drug Development and Industrial Pharmacy|February 19, 2020
Preparation and optimization of nilotinib self-micro-emulsifying drug delivery systems to enhance oral bioavailabilityAshok Zakkula, Bhavesh Babulal Gabani, Ravi Kumar Jairam, et al.
Biomedical Chromatography : BMC|January 31, 2020
Validated LC-MS/MS method for quantitation of a selective JAK1 inhibitor, filgotinib in rat plasma, and its application to a pharmacokinetic study in ratsAbhishek Dixit, Vinay Kiran, Bhavesh Babulal Gabani, et al.
Biomedical Chromatography : BMC|July 25, 2020
A dried blood spot assay with HPLC-MS/MS for the determination of larotrectinib in mouse blood and its application to a pharmacokinetic studyHarsha K Tripathy, Nair S V Manju, Sreekanth Dittakavi, et al.
Biomedical Chromatography : BMC|January 28, 2015
Development and validation of a RP-HPLC method for the quantitation of tofacitinib in rat plasma and its application to a pharmacokinetic studyVijay Kumar S, Vinay Dhiman, Kalpesh Kumar Giri, et al.
Biomedical Chromatography : BMC|July 25, 2016
Determination of epacadostat, a novel IDO1 inhibitor in mouse plasma by LC-MS/MS and its application to a pharmacokinetic study in miceVinay Dhiman, Kalpesh Kumar Giri, Suresh P S, et al.
Biomedical Chromatography : BMC|February 23, 2012
Development and validation of a highly sensitive LC-MS/MS-ESI method for the determination of nobiletin in rat plasma: application to a pharmacokinetic studyAvinash Kumar, V C Devaraj, Kalpesh C Giri, et al.
Biomedical Chromatography : BMC|May 1, 2012
Simultaneous determination of sitagliptin and simvastatin in human plasma by LC-MS/MS and its application to a human pharmacokinetic studyLaxminarayana Burugula, Ramesh Mullangi, Nageswara Rao Pilli, et al.
Biomedical Chromatography : BMC|September 28, 2010
Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic studySandip Dhondiram Gurav, Ravindranath Reddy Gilibili, Sherine Jeniffer, et al.
Pageof 19